Investor Relations

Focused on enhancing shareholder value through creating and delivering meaningful advancements in early intervention orthopedic care.
Stock quote is delayed by 15 minutes
NASDAQANIK
Woman throwing punch at punching bag.

Investor Relations

Focused on enhancing shareholder value through creating and delivering meaningful advancements in early intervention orthopedic care.
Stock quote is delayed by 15 minutes
NASDAQANIK
Financial and Operational Metrics

(As of December 31, 2021)

  • $148M

    FY’21 Revenue

    13% YtY Growth

    (10% organic)

  • 23%

    YtY growth (FY'21)

    Joint Preservation and Restoration

    (12% organic)

  • #1

    U.S. Market Share

    OA Pain Management

  • $94M

    Cash balance
    with no debt

Recent News
May 13, 2022

BEDFORD, Mass., May 13, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on May 2, 2022, Anika granted...

May 9, 2022

BEDFORD, Mass. — May 9, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate...

May 5, 2022

BEDFORD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results...

All Press Releases

Current Investor Presentation
Investor Contacts

Primary IR Contact

  • Mark Namaroff

    Vice President, Investor Relations, ESG, and Corporate Communications

    Anika Therapeutics, Inc.

    Phone: (781) 457-9287

    Email: investorrelations@anika.com

  • Transfer Agent

    American Stock Transfer & Trust Co.

    59 Maiden Lane

    New York, NY 10038

    Phone: (718) 921-8261

Want Alerts? Sign up for alerts and never miss an Investor update!

Subscribe

To Top